BPC
CRL icon

Banque Pictet & Cie’s Charles River Laboratories CRL Stock Holding History

Banque Pictet & Cie’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,161
Closed -$1.93M – 453
2023
Q2 		$1.93M Buy
+9,161
New +$1.82M 0.02% 252

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Banque Pictet & Cie's CRL Position: Q3 2023 in Review

Banque Pictet & Cie sold out of Charles River Laboratories (CRL) in Q3 2023, closing a stake of 9,161 shares — an estimated $1.93M sold.

Banque Pictet & Cie first reported a position in CRL in Q2 2023 and held it in 1 quarter. The position peaked at $1.93M in Q2 2023. 621 funds tracked by Wall St. Rank hold CRL as of Q3 2023.

  • Banque Pictet & Cie reported no remaining Charles River Laboratories position as of Q3 2023 after selling out during the quarter.
  • Banque Pictet & Cie sold 9,161 Charles River Laboratories shares in Q3 2023, an estimated $1.93M.
  • Banque Pictet & Cie first reported a position in Charles River Laboratories in Q2 2023 and held it in 1 quarter.
  • Banque Pictet & Cie's Charles River Laboratories position peaked at $1.93M in Q2 2023.
  • 621 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2023.

Based on Banque Pictet & Cie's 13F filing for Q3 2023, filed 2 Nov 2023.